PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34651654-4	2022	Treatment with prednisolone (PSL), mycophenolate mofetil (MMF), and tacrolimus (TAC) resulted in improved SLE activity and glucose intolerance with the reduction of anti-insulin receptor autoantibodies.	Prednisolone	15-27	insulin receptor	Homo sapiens	170-186	
34651654-4	2022	Treatment with prednisolone (PSL), mycophenolate mofetil (MMF), and tacrolimus (TAC) resulted in improved SLE activity and glucose intolerance with the reduction of anti-insulin receptor autoantibodies.	Prednisolone	29-32	insulin receptor	Homo sapiens	170-186	
20190490-4	2010	Intravenous boluses of cyclophosphamide (IVCY) with oral prednisolone and cyclosporin A induced remission of SLE, and a subsequent disappearance of anti-insulin receptor autoantibodies, followed by a recovery of glucose intolerance.	Prednisolone	57-69	insulin receptor	Homo sapiens	153-169	
18218307-7	2008	Treatment with steroid pulse and subsequent high dose of prednisolone resulted in restoration of euglycemia associated with disappearance of insulin receptor antibodies and improvement of both serum hypocomplementemia and the high titer of ANA.	Prednisolone	57-69	insulin receptor	Homo sapiens	141-157